Skip to main content
Deepakbabu Chellapandian, MD, Pediatric Hematology & Oncology, Saint Petersburg, FL

DeepakbabuChellapandianMDMBBS

Pediatric Hematology & Oncology Saint Petersburg, FL

BMT Physician at Johns Hopkins All Children's Hospital

Dr. Chellapandian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chellapandian's full profile

Already have an account?

  • Office

    601 Fifth Street South
    Suite 302
    Saint Petersburg, FL 33701
    Phone+1 727-767-6856

Summary

  • Dr. Deepakbabu Chellapandian is a pediatric hematologist/oncologist in Saint Petersburg, FL and is affiliated with Johns Hopkins All Children's Hospital. He received his medical degree from Madurai Medical College and has been in practice 13 years. He is experienced in bone marrow transplantation and hemophagocytic lymphohistiocytosis.

Education & Training

  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology, 2013 - 2017
  • Albert Einstein Healthcare Network
    Albert Einstein Healthcare NetworkResidency, Pediatrics, 2010 - 2013
  • Madurai Medical College
    Madurai Medical CollegeClass of 2004

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2025
  • TN State Medical License
    TN State Medical License 2016 - 2018
  • PA State Medical License
    PA State Medical License 2010 - 2016
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Through Teamwork, Sickle Cell Disease Strikes Out
    Through Teamwork, Sickle Cell Disease Strikes OutSeptember 24th, 2019
  • Low-Income Floridian with Sickle Cell Disease Will Have Access to New Gene Therapies
    Low-Income Floridian with Sickle Cell Disease Will Have Access to New Gene TherapiesJune 20th, 2024